NSE filing, NSE: VEEDOL. Summary written from the filing by ALFA Finder's alert engine.
Veedol Corporation Ltd: key numbers
- Share price
- ₹1,336.10
- Market cap
- ₹2,328 Cr
- Revenue (annual)
- ₹2,169 Cr
- Net profit (annual)
- ₹191.6 Cr
- P/E (TTM)
- 10.6×Sector 17.7×
- Promoter holding
- 64.58%+0.00% QoQ
- FII holding
- 1.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Veedol Corporation Ltd
All →Veedol Corporation Board Meeting Date
Veedol Corporation will hold a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated results for the half year ended September 2026 and a possible interim dividend. The trading window remains closed until 48 hours after the results.
Veedol Corporation Management Change
Veedol Corporation disclosed the resignation of Mr. Ranesh Sinha as Vice President – Manufacturing (SMP), effective 24 November 2026. This is a senior management departure disclosed under Regulation 30.
Veedol Corporation Promoter Buying (Off-Market)
Veedol Corporation announced an off-market inter-se transfer of 2,95,000 shares between promoter entities Janus Consolidated and Standard Greases. The group's aggregate shareholding remains unchanged.
Veedol Corporation Management Change
Veedol Corporation Limited announces the resignation of Mr. Murli Vasudevan, Vice President – Sales (After Market), effective from the close of business on December 24, 2026.
Veedol Corporation Debt & Borrowing: ₹10 Cr
Veedol Corporation Limited's board approved a short-term unsecured loan of up to Rs. 10 Crore to its promoter, Andrew Yule & Company Limited. The loan carries 12% interest.
- Value
- ₹10.00 Cr
- Execution
- Repayable by 31st March, 2027
Veedol Corporation Annual General Meeting
Veedol Corporation shareholders approved a Rs. 650 Crore related party transaction with Standard Greases & Technologies via postal ballot.
- Value
- ₹650.0 Cr
- Execution
- 1 year
Other adverse business impact announcements
All →Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.